/Companies

AlphaRose Therapeutics

2 known investors

Find your way into AlphaRose Therapeutics

Sign up to see every warm intro you have to AlphaRose Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AlphaRose Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AlphaRose Therapeutics is a public-benefit precision medicine company developing and commercializing genetic disease treatments for small patient populations affected by rare genetic diseases. It aims to create a new business model for delivering personalized medicines in the biotech and pharmaceutical sectors.

Founders & leadership

CM
Casey McPhersonFounder & CEO
BT
Belinda TermeerCo-founder
AW
Alan WaltsCo-founder & Executive Chairman
MN
Masako NakamuraPresident & Chief Operating Officer
RC
Robert CabreraChief Science Officer
RB
Rodney Bowling Jr.CSO of RareLabs

Investors · 2

In the news

Frequently asked questions

What does AlphaRose Therapeutics do?
AlphaRose Therapeutics is a public-benefit precision medicine company developing and commercializing genetic disease treatments for small patient populations affected by rare genetic diseases. It aims to create a new business model for delivering personalized medicines in the biotech and pharmaceutical sectors.
Who are AlphaRose Therapeutics's investors?
AlphaRose Therapeutics's investors include Advent Life Sciences, Suncoast Ventures.